§ Mr. Waterson
To ask the Secretary of State for Health if he will list the centres at which the drugs Avonex, Betaferon, Copaxone and Rebif will be provided to multiple sclerosis (MS) patients; and how many MS patients are waiting to be assessed for treatment with these drugs. 
§ Mr. Lammy
It has been estimated that up to 9,000 multiple sclerosis (MS) patients in England and Wales may be eligible to receive treatment under the risk-sharing scheme, which started on 6 May 2002. Some centres have now started prescribing under the scheme, though the guidance in HSC 2002–04 recognises that appropriate national health service infrastructure may not yet be in place in some localities. It may take 18 months or longer before all potentially eligible patients are assessed under1218W
§ Jacqui Smith
The teenage pregnancy national media campaign consists of press and radio adverts, underpinned by public relations and partnership work. Expenditure was £2.2 million in 2000–01 and £2.5 million in 2001–02. We expect investment this year to be at least £2.5 million.